Skip to main content

Advertisement

Log in

Increased Prevalence of Gastrointestinal Viruses and Diminished Secretory Immunoglobulin a Levels in Antibody Deficiencies

  • Original Research
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Purpose

Gastrointestinal disease occurs frequently in antibody deficiencies. This study aims to explore the relation between gastrointestinal infections and mucosal homeostasis in patients with antibody deficiencies.

Methods

We performed an observational study including 54 pediatric antibody deficient patients (48 % CVID, 41 % CVID-like, 11 % XLA) and 66 healthy controls. Clinical symptom scores and stool samples were collected prospectively. Stool samples were evaluated for bacteria, parasites, viruses, secretory IgA- and for calprotectin levels. Results were compared between patients and controls.

Results

24 % of antibody deficient patients versus 9 % of healthy controls tested positive for gastrointestinal viruses (p = 0.028). Fecal calprotectin levels were significantly higher in virus positive patients compared to virus negative patients (p = 0.002). However, in controls, fecal calprotectin levels were similar between virus positive and virus negative controls. Moreover, gastrointestinal virus positive patients had low serum IgA levels in 13/14 cases (94 %) versus 40/62 (62 %) patients in the virus negative patient group (p = 0.04). The virus positive patient group also displayed significantly lower secretory IgA levels in stool (median 13 ug/ml) than patients without gastrointestinal viruses detected or healthy controls (median 155 ug/ml) (p = 0.046).

Conclusion

We here report an increased prevalence of gastrointestinal viruses and gastrointestinal complaints in antibody deficient patients. Patients that tested positive for gastrointestinal viruses showed diminished serum- and secretory IgA levels, and only in patients, virus positivity was associated with signs of mucosal inflammation. These findings suggest that particularly patients with low IgA are at risk for longstanding replication of gastrointestinal viruses, which may eventually result in CVID-related enteropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

CVID:

Common variable immunodeficiency

GI:

Gastrointestinal

IBD:

Inflammatory bowel disease

IgA:

Immunoglobulin A

PID:

Primary immunodeficiencies

XLA:

X-linked agammaglobulinemia

RT-PCR:

Real time polymerase chain reaction

ELISA:

Enzyme-linked immunosorbent assay

References

  1. Salzer U, Warnatz K, Peter HH. Common variable immunodeficiency - an update. Arthritis Res Ther. 2012;14(5):223. doi:10.1186/ar4032.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93(3):190–7.

    Article  CAS  PubMed  Google Scholar 

  3. Park MA, Li JT, Hagan JB, Maddox DE, Abraham RS. Common variable immunodeficiency: a new look at an old disease. Lancet. 2008;372(9637):489–502. doi:10.1016/S0140-6736(08)61199-X.

    Article  PubMed  Google Scholar 

  4. Agarwal S, Mayer L. Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes. J Allergy Clin Immunol. 2009;124(4):658–64. doi:10.1016/j.jaci.2009.06.018.

    Article  CAS  PubMed  Google Scholar 

  5. Agarwal S, Mayer L. Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. Clin Gastroenterol Hepatol. 2013;11(9):1050–63. doi:10.1016/j.cgh.2013.02.024.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119(7):1650–7. doi:10.1182/blood-2011-09-377945.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112(2):277–86. doi:10.1182/blood-2007-11-124545.

    Article  CAS  PubMed  Google Scholar 

  8. Malamut G, Verkarre V, Suarez F, Viallard JF, Lascaux AS, Cosnes J, et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol. 2010;105(10):2262–75. doi:10.1038/ajg.2010.214.

    Article  CAS  PubMed  Google Scholar 

  9. Teahon K, Webster AD, Price AB, Weston J, Bjarnason I. Studies on the enteropathy associated with primary hypogammaglobulinaemia. Gut. 1994;35(9):1244–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Daniels JA, Lederman HM, Maitra A, Montgomery EA. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol. 2007;31(12):1800–12. doi:10.1097/PAS.0b013e3180cab60c.

    Article  PubMed  Google Scholar 

  11. Agarwal S, Smereka P, Harpaz N, Cunningham-Rundles C, Mayer L. Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease. Inflamm Bowel Dis. 2011;17(1):251–9. doi:10.1002/ibd.21376.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Packwood K, Drewe E, Staples E, Webster D, Witte T, Litzman J, et al. NOD2 polymorphisms in clinical phenotypes of common variable immunodeficiency disorders. Clin Exp Immunol. 2010;161(3):536–41. doi:10.1111/j.1365-2249.2010.04216.x.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Akram S, Murray JA, Pardi DS, Alexander GL, Schaffner JA, Russo PA, et al. Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin Gastroenterol Hepatol. 2007;5(11):1282–90. doi:10.1016/j.cgh.2007.05.013. quiz 45.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Catassi C, Mirakian R, Natalini G, Sbarbati A, Cinti S, Coppa GV, et al. Unresponsive enteropathy associated with circulating enterocyte autoantibodies in a boy with common variable hypogammaglobulinemia and type I diabetes. J Pediatr Gastroenterol Nutr. 1988;7(4):608–13.

    Article  CAS  PubMed  Google Scholar 

  15. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92(1):34–48. doi:10.1006/clim.1999.4725.

    Article  CAS  PubMed  Google Scholar 

  16. Quinti I, Soresina A, Spadaro G, Martino S, Donnanno S, Agostini C, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol. 2007;27(3):308–16. doi:10.1007/s10875-007-9075-1.

    Article  PubMed  Google Scholar 

  17. Oksenhendler E, Gerard L, Fieschi C, Malphettes M, Mouillot G, Jaussaud R, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis. 2008;46(10):1547–54. doi:10.1086/587669.

    Article  PubMed  Google Scholar 

  18. Resnick ES, Cunningham-Rundles C. The many faces of the clinical picture of common variable immune deficiency. Curr Opin Allergy Clin Immunol. 2012;12(6):595–601. doi:10.1097/ACI.0b013e32835914b9.

    Article  PubMed  Google Scholar 

  19. Mantis NJ, Forbes SJ. Secretory IgA: arresting microbial pathogens at epithelial borders. Immunol Investig. 2010;39(4–5):383–406. doi:10.3109/08820131003622635.

    Article  CAS  Google Scholar 

  20. Cerutti A, Cols M, Gentile M, Cassis L, Barra CM, He B, et al. Regulation of mucosal IgA responses: lessons from primary immunodeficiencies. Ann N Y Acad Sci. 2011;1238:132–44. doi:10.1111/j.1749-6632.2011.06266.x.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Mantis NJ, Rol N, Corthesy B. Secretory IgA’s complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol. 2011;4(6):603–11. doi:10.1038/mi.2011.41.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Espanol T, Catala M, Hernandez M, Caragol I, Bertran JM. Development of a common variable immunodeficiency in IgA-deficient patients. Clin Immunol Immunopathol. 1996;80(3 Pt 1):333–5.

    Article  CAS  PubMed  Google Scholar 

  23. van de Ven AA, Douma JW, Rademaker C, van Loon AM, Wensing AM, Boelens JJ, et al. Pleconaril-resistant chronic parechovirus-associated enteropathy in agammaglobulinaemia. Antivir Ther. 2011;16(4):611–4. doi:10.3851/IMP1792.

    Article  PubMed  Google Scholar 

  24. Joshi S, Lewis SJ, Creanor S, Ayling RM. Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers. Ann Clin Biochem. 2010;47(Pt 3):259–63. doi:10.1258/acb.2009.009061.

    Article  CAS  PubMed  Google Scholar 

  25. Roseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol. 1999;34(1):50–4.

    Article  CAS  PubMed  Google Scholar 

  26. Lundberg JO, Hellstrom PM, Fagerhol MK, Weitzberg E, Roseth AG. Technology insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol. 2005;2(2):96–102. doi:10.1038/ncpgasthep0094.

    Article  CAS  PubMed  Google Scholar 

  27. Cerutti A, Rescigno M. The biology of intestinal immunoglobulin a responses. Immunity. 2008;28(6):740–50. doi:10.1016/j.immuni.2008.05.001.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Cerutti A, Chen K, Chorny A. Immunoglobulin responses at the mucosal interface. Annu Rev Immunol. 2011;29:273–93. doi:10.1146/annurev-immunol-031210-101317.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Pabst O. New concepts in the generation and functions of IgA. Nat Rev Immunol. 2012;12(12):821–32. doi:10.1038/nri3322.

    Article  CAS  PubMed  Google Scholar 

  30. Shulzhenko N, Morgun A, Hsiao W, Battle M, Yao M, Gavrilova O, et al. Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat Med. 2011;17(12):1585–93. doi:10.1038/nm.2505.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Dion C, Montagne P, Bene MC, Faure G. Measurement of faecal immunoglobulin a levels in young children. J Clin Lab Anal. 2004;18(3):195–9. doi:10.1002/jcla.20022.

    Article  CAS  PubMed  Google Scholar 

  32. Aghamohammadi A, Mohammadi J, Parvaneh N, Rezaei N, Moin M, Espanol T, et al. Progression of selective IgA deficiency to common variable immunodeficiency. Int Arch Allergy Immunol. 2008;147(2):87–92. doi:10.1159/000135694.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Jessica van der Aa and Géanne Krabben for assistance with participant inclusions and Karin van Veghel and Lysette Ebskamp of U-DAIR with determination of sIgA levels.

Funding

This study was supported by non-restricted educational grants from Baxter The Netherlands and GlaxoSmithKline The Netherlands.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. M. van Montfrans.

Additional information

A.A.J.M. van de Ven W.J.M. Janssen, A.M.J. Wensing and J.M. van Montfrans have equal contributions.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

van de Ven, A.A.J.M., Janssen, W.J.M., Schulz, L.S. et al. Increased Prevalence of Gastrointestinal Viruses and Diminished Secretory Immunoglobulin a Levels in Antibody Deficiencies. J Clin Immunol 34, 962–970 (2014). https://doi.org/10.1007/s10875-014-0087-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-014-0087-3

Keywords

Navigation